1. ATIM-15. A PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN ADULTS WITH RECURRENT GLIOBLASTOMA: DOSE DETERMINATION WITH UPDATED OVERALL SURVIVAL. (5th November 2018) Authors: Chiocca, E Antonio; Lukas, Rimas; Yu, John; Oberheim Bush, Nancy Ann; Buck, Jill; Demars, Nathan; Barrett, John; Gelb, Arnold; Wang, Yunxia; Cooper, Laurence; Lebel, Francois Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATIM-18. SURVIVAL OF SUBJECTS WITH RECURRENT GLIOBLASTOMA RECEIVING INTRA-TUMORAL ADMINISTRATION OF IL-12 MANAGED WITH LOW-DOSE DEXAMETHASONE. (11th November 2019) Authors: Lukas, Rimas; Chiocca, Ennio; Kurz, Sylvia; Yu, John; Landolfi, Joseph; Rao, Ganesh; Buck, Jill; Demars, Nathan; Smith, Amy; Miao, John; Zhou, John; Wang, Yunxia; Gelb, Arnold; Cooper, Laurence Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ATIM-25. PD-1 INHIBITION CAN BE COMBINED WITH IL-12 IN SUBJECTS WITH RECURRENT GLIOBLASTOMA. (11th November 2019) Authors: Chiocca, Ennio; Lukas, Rimas; Rao, Ganesh; Buck, Jill; Demars, Nathan; Smith, Amy; Miao, John; Zhou, John; Gelb, Arnold; Cooper, Laurence Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy. (7th November 2013) Authors: Rushworth, David; Mi, Tiejuan; Olivares, Simon; Carrero, Rosa Santana; Yang, Ge; Najjar, Amer; Cooper, Laurence Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial. Issue 6 (26th November 2021) Authors: Chiocca, E Antonio; Gelb, Arnold B; Chen, Clark C; Rao, Ganesh; Reardon, David A; Wen, Patrick Y; Bi, Wenya Linda; Peruzzi, Pierpaolo; Amidei, Christina; Triggs, Dan; Seften, Leah; Park, Grace; Grant, James; Truman, Kyla; Buck, Jill Y; Hadar, Nira; Demars, Nathan; Miao, John; Estupinan, Taylor; L... Journal: Neuro-oncology Issue: Volume 24:Issue 6(2022) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTIM-05. COMBINATION OF CONTROLLED INTERLEUKIN-12 GENE THERAPY WITH IMMUNE CHECKPOINT BLOCKADE IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS OF A MULTI-INSTITUTIONAL, OPEN LABEL PHASE 1 TRIAL. (9th November 2020) Authors: Antonio Chiocca, E; Lukas, Rimas; Chen, Clark; Rao, Ganesh; Amidei, Christina; Buck, Jill; Hadar, Nira; Demars, Nathan; Miao, John; Estupinan, Taylor; Loewy, John; Wang, Yunxia; Gelb, Arnold; Cooper, Laurence Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTIM-27. PHASE I/II STUDY OF CONTROLLED IL-12 AS IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). (9th November 2020) Authors: Goldman, Stewart; Mueller, Sabine; Chi, Susan; Saratsis, Amanda; Allen, Rudy; Buck, Jill; Demars, Nathan; Hadar, Nira; Estupinan, Taylor; Miao, John; Walsh, Erin; Gelb, Arnold; Cooper, Laurence Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTIM-28. PHASE 2 TRIAL OF CONTROLLED IL-12 IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA (rGBM). (9th November 2020) Authors: Lukas, Rimas; Chiocca, E Antonio; Bush, Nancy Ann Oberheim; Landolfi, Joseph; Cavaliere, Robert; Yu, John; Kurz, Sylvia; Demars, Nathan; Buck, Jill; Hadar, Nira; Miao, John; Loewy, John; Wang, Yunxia; Gelb, Arnold; Cooper, Laurence Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EAPH-13. PHASE I STUDY OF INTRAVENTRICULAR INFUSIONS OF AUTOLOGOUS EX VIVO EXPANDED NK CELLS IN CHILDREN WITH RECURRENT/REFRACTORY MALIGNANT POSTERIOR FOSSA TUMORS OF THE CENTRAL NERVOUS SYSTEM. Issue 2 (22nd June 2018) Authors: Khatua, Soumen; Gopalakrishnan, Vidya; Sandberg, David; Ketonen, Leena; Johnson, Jason; Cooper, Laurence; Moyes, Judy; Lee, Dean; Meador, Heather; Rytting, Michael; Liu, Diane; Zaky, Wafik Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies. (4th November 2015) Authors: Smith, Jenessa B; Panjwani, M Kazim; Schutsky, Keith; Gnanandarajah, Josephine; Calhoun, Sondra; Cooper, Laurence; Mason, Nicola; Powell, Daniel J Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗